About Sanai
AI-native document workflows
for life sciences teams
Sanai Inc. builds artificial intelligence for the pharmaceutical and biotechnology industries, with drug developers and AI engineers working side by side.
Contact Us4.2 Scientific rationale
Built for the agencies and standards you work with
- FDAUnited States
- EMAEuropean Union
- ICHGuidelines
- Health CanadaCanada
- MHRAUnited Kingdom
- PMDAJapan
- eCTDSubmissions
Sanai prepares documents for FDA, EMA, Health Canada, MHRA and PMDA submissions, following ICH guidelines and eCTD structure.
ABOUT US
A company focused on life sciences
We are transforming the way pharmaceutical companies do business by harnessing the power of artificial intelligence to accelerate drug development, reduce development costs, and deliver maximal returns on your R&D investments.
With our team of experienced drug developers and skilled AI engineers, we are your partner of choice in shaping the AI future of your life sciences organization. Your products transform human lives for the better; let our pharma-focused AI platform transform yours.
THE PEOPLE BEHIND SANAI
Leadership Team
Meet the experienced leaders driving innovation in AI-powered pharmaceutical solutions.
John Walters
CEO
Serial entrepreneur and life sciences leader with experience scaling organizations from pre-clinical to commercial. 10+ years in Leadership roles with Twist Bioscience, Applied Molecular Science, Thermofisher Scientific.
Magic Madrigal
CTO
Head of Enterprise Engineering and AI architect, with experience in AI and SaaS. Leadership role in leading Reddit through IPO, with a focus on compliance.
Zachary Betts
Chief Business Officer
Industry leader in global enterprise technology delivery (ex-Deloitte/Accenture/Oracle), GxP regulatory program and quality management, growth stage expansion, with venture capital and portfolio partnerships across life sciences.
Mo
Commercial Development & Investor Relations
Board-certified anesthesiologist with a decade in practice, affiliated with NewYork-Presbyterian. At Sanai he leads commercial strategy, partnerships, and clinical and regulatory positioning, working directly with pharma R&D, regulatory, and quality teams. Seven years as a board advisor and early investor to Raydiant Oximetry, a Class III device with FDA Breakthrough Device Designation, and an angel investor in healthcare and medtech since 2017.
01 / What we exist to do
Mission Statement
Sanai's mission is to build intelligent automation for the life-science industry to dramatically reduce the cost of innovation. Health is a fundamental human right and the potential to achieve radical improvement in therapeutic outcomes is well-within reach with the right tooling. Every dollar in research counts and adding a force multiplier to innovation will directly contribute to a better world.
02 / Where we're headed
Vision Statement
Our vision goes beyond just reducing cost, but also to fundamentally open new doors of research that are not feasible by traditional human methods today. By reducing financial risk for innovators as well as their investors and donors, we aim to create a virtuous cycle that attracts more funding to solve the critical problems facing human health today. Creating end-to-end intelligent automation for the development process would radically transform the rate at which new therapies come to market.
OUR PRINCIPLES
Brand Values
What we stand for
Patient Safety
Safety always comes first. We are committed to ensuring transparency for human oversight and making confirmation of results effortless.
Accuracy
We believe in accuracy-first automation. Creating controls at every failure mode in order to produce error-free results is critical to the sustainability of this effort.
Efficiency
We believe too much time and money is spent on tasks that should be automated, thus stifling innovation.
CUSTOMER STORIES
What teams say about Sanai
As a VP of Quality Assurance, audits are a critical part of my role. Sanai’s AI-powered document management query engine has been a game-changer.
A clinical trial document such as a protocol is a time-consuming and labor-intensive activity, taking many weeks and multiple team members to contribute. Sanai can draft in minutes and finalize in days.
Having an easily searchable knowledge base where anyone in the company can find the information they need is a huge time saver for a QA professional. My coworkers can find the forms and processes they need to complete a task right the first time.
Finding the right data used to take hours. Now I get precise results in seconds, with full context about where the information came from.
The AI understands our GxP language better than most junior staff. It's like having a GxP expert available 24/7.
Cross-study comparisons that used to require weeks of manual review now happen instantly with full confidence in the results.
Automated Authoring understands our regulatory language better than most medical writers. It's like having a senior writer available 24/7.
We've cut our CSR writing time by 80% while actually improving quality and consistency across our submission documents.
The AI catches regulatory compliance issues that would typically take weeks of review to identify. It's a game-changer for our team.
Sanai Docs eliminated our document chaos. We now have complete visibility into our regulatory document landscape with full compliance confidence.
Version control used to be our biggest headache. Now we track every change automatically with complete impact analysis.
The automated compliance checking has prevented multiple submission delays. It's like having a regulatory expert reviewing every document.
Finally, a tool that understands medical writing isn't just about grammar—it's about compliance, accuracy, and clear communication.
We've stretched our grant budget 40% further by reducing the time spent on document formatting and revisions.
The institutional review process used to be our bottleneck. Now we submit cleaner documents that sail through approval.